GO
Loading...

Corporate Leaders

More

  • Genentech In 2007: Stock Ends Down, Exec Comp Goes Up Thursday, 13 Mar 2008 | 12:26 PM ET

    Last year Genentech shares traded as high as nearly 88 dollars, but ended 2007 around 67 bucks. But according to the company's new proxy statement all of Genentech's top-tier executives saw their total compensation go up.

  • Northrop CEO: Airbus Deal Will Build 4 US Plants Thursday, 13 Mar 2008 | 9:55 AM ET

    Northrop Grumman CEO Ronald Sugar says his company plans to build four factories in the United States as part of a partnership with European Aeronautic Defence and Space (EADS).

  • Your Say on Jim Rogers and the Fed Thursday, 13 Mar 2008 | 9:17 AM ET

    The last week has seen the Fed throw more money at the banking system -- and the markets have apparently shrugged-off the positives. After a brief flattening in the Treasury curve, the markets returned to their default view that the Fed has lost control of the situation and credit market distress is the most important story in the room.

  • Property Profits Beckon for Smart Investors Thursday, 13 Mar 2008 | 6:13 AM ET

    The subprime crisis may have wiped billions of dollars off the value of global real estate markets, but it is much easier to make money in today's market than a year ago, the joint CEO of RREEF Europe told Reuters.

  • On the Line: Darling International CEO Randal Stuewe Wednesday, 12 Mar 2008 | 7:27 PM ET

    Finally, a stock that touches on three key trends: animal feed, biofuel and the environment.

  • Cramer Gets Raw With WWE Wednesday, 12 Mar 2008 | 2:04 PM ET

    CEO Linda McMahon explains why her company's a true intercontinental champion.

  • 0% Financing is Back! (That's Good & Bad) Wednesday, 12 Mar 2008 | 10:29 AM ET

    You figured the automakers would eventually scream "UNCLE!" I'm not sure it's a scream, but it's more than just a whisper. One thing is clear: the automakers are once again turning to 0 percent financing to spur sales that are stalling.

  • Bear Stearns CEO:  No Liquidity Crisis for Firm Wednesday, 12 Mar 2008 | 10:12 AM ET

    The chief executive of Bear Stearns  told CNBC that despite recent market volatility, he is not aware of any imminent threat to the Wall Street investment bank's liquidity.

  • A SPA Break For Dendreon Wednesday, 12 Mar 2008 | 10:08 AM ET

    Everyone's favorite small-cap biotech put out a press release this morning, announcing that the Food and Drug Administration has agreed to change the Special Protocol Assessment (SPA) for Dendreon's Provenge.

  • Iger:  Disney Strong, No Downturn Yet Wednesday, 12 Mar 2008 | 8:41 AM ET

    The president and chief executive of the Walt Disney Company says his company is not recession-proof, but it is positioned well enough to avoid being badly hurt in an downturn.

  • One Giant Leap for MannKind Monday, 10 Mar 2008 | 5:11 PM ET

    Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.

  • Freeport McMoran's Saving Grace: China Monday, 10 Mar 2008 | 1:26 PM ET

    Despite signs of an economic pullback in the United States, Freeport McMoran Copper & Gold  is not worried about its business. Why? China is likely to pick up the slack.

  • Merrill Lynch CEO Says Worst is Over Monday, 10 Mar 2008 | 5:56 AM ET

    U.S. bank Merrill Lynch will not need to return to the market again following the turbulence in credit markets that forced it to raise nearly $13 billion, its chief executive was quoted as saying.

  • Tour de Salesforce.com Friday, 7 Mar 2008 | 7:23 PM ET

    This is quite possibly the last momentum stock around. Here's why the CEO thinks the growth will continue.

  • Blockbuster Is Back Friday, 7 Mar 2008 | 7:22 PM ET

    The risk will make you queasy, but the reward might be worth it.

  • First, Pfizer gave up on its inhaled insulin Exubera, then NovoNordisk threw in the towel and now it looks like Lilly is going to bow out. Alkermes, which is working on a palm-sized product called, "AIR Insulin," put out a press release today saying it expects its partner on the device, Lilly, to decide next week that it will exit the deal. ALKS shares hit a new low on the news.

  • Congress Rips Lavish Pay of Subprime CEOs Friday, 7 Mar 2008 | 2:03 PM ET

    The stunning pay packages of executives at financial groups hammered by the U.S. mortgage crisis came in for stinging criticism from Democratic lawmakers and investor advocates at a congressional hearing Friday.

  • Analyst: Pfizer Should Buy Amgen or Wyeth Friday, 7 Mar 2008 | 10:48 AM ET

    I thought I was finished with the post-Pfizer analyst meeting reaction with yesterday's post, but when an extraordinarily bearish 77-page research note from Credit Suisse big pharma analyst Catherine Arnold arrived in my inbox this morning, I had to do one more installment. She thinks Pfizer should buy Wyeth or Amgen...

  • Countrywide: Mortgage Controls Have Gone Too Far Friday, 7 Mar 2008 | 10:42 AM ET

    Countrywide Financial CEO Angelo Mozilo told a congressional panel Friday that he is "extremely concerned" that recent tightening of mortgage underwriting criteria has gone too far.

  • Banks CEOs Face Grilling over Compensation Friday, 7 Mar 2008 | 7:25 AM ET

    The heads of three companies implicated in the mortgage crisis have been asked to explain how they collectively received hundreds of millions of dollars in compensation while their companies were losing money.

Most Popular Video

Tuesday, 15 Apr 2014 | 11:36 PM ET

John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, expects Alibaba to push on with its buying spree after listing in the U.S.

Thursday, 17 Apr 2014 | 4:00 PM ET

On this week's "$ave Me," CNBC's Kelli Grant gives tips on how to finally earn enough for that free airline award seat.

Thursday, 17 Apr 2014 | 12:58 PM ET

The FMHR traders reveal their final trades.